Table (1).
Experimental Models | Approaches | Observations | References |
---|---|---|---|
In vitro models use to study CDDP-induced nephrotoxicity | |||
Yeast | Deletion of Ctr1 transporter to track changes in CDDP uptake | Increased CDDP resistance and reduced intracellular accumulation | [41] |
Mouse cell lines | Lack of Ctr1 alleles to study changes in CDDP uptake | Increased CDDP resistance and reduced intracellular accumulation | [41] |
Human PTs from healthy kidneys | Cimetidine OCT2 inhibition to track changes in CDDP uptake | Decreased CDDP uptake | [43] |
Human PTs from diabetic kidneys | Reduced OCT2 expression due to diabetic condition | Decreased CDDP uptake | [2, 43] |
TNFR1-deficient cells | Ablation of TNFR1 gene | Increased resistance to CDDP-induced cell death | [53] |
Fas-mutant cells | Effect of Fas gene ablation on the Fas-mediated apoptotic pathway | Increased resistance to CDDP-induced cell death | [53] |
Rabbit PTCs | p53 inhibition | Decreased CDDP-induced apoptosis | [58, 68, 71] |
In vivo models use to study CDDP-induced nephrotoxicity | |||
TNFR1-deficient mice TNFR2-deficient mice |
Ablation of TNFR1 or TNFR2 gene to study changes in CDDP pathogenesis | Amelioration of CDDP-induced renal failure | [53, 86] |
TNF-α-deficient mice | Effect of TNF-α deficiency in the activation of cytokines due to CDDP | Resistance to CDDP-nephrotoxicity | [2, 52] |
Fas-mutant mice | Ablation of Fas gene to reveal its involvement on CDDP-induced cell death | Diminished CDDP-induced cell death and renal dysfunction | [53] |
Bax-deficient mice | Bax gene knocked out to determine the pathological role of Bax | Decreased apoptosis and tissue damage induced by CDDP | [50] |
JNK inhibition rat model | Inhibition of JNK using SP600125 | Reduction of the apoptotic cell death and inflammation due to CDDP | [88] |
OCT1/OCT2-deficient mice | Role of OCTs in CDDP oto- and nephron-toxicity | Reduced CDDP toxicity | [43, 44] |
nu/nu mice (T-cell deficient) | Possible protective effects of CD+4CD25+Treg cells | Attenuation of CDDP-induced renal dysfunction and tubular injury, and increased survival | [9] |
CD4- or CD8-T-cell-deficient mice | Role for T-lymphocytes on CDDP-induced AKI | Attenuation of renal dysfunction after CDDP administration | [101] |